SciSparc Ltd. (NASDAQ:SPRC) Sees Significant Increase in Short Interest

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,030,000 shares, a growth of 1,435.0% from the February 28th total of 67,100 shares. Based on an average trading volume of 9,770,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 9.5% of the shares of the stock are sold short.

SciSparc Stock Down 1.0 %

Shares of SciSparc stock opened at $0.31 on Friday. The firm’s 50 day moving average is $0.43 and its 200 day moving average is $0.35. SciSparc has a 1 year low of $0.20 and a 1 year high of $2.10.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.